These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6370151)

  • 21. Pharmacokinetic interactions of penicillamine in rheumatoid arthritis.
    Seideman P; Lindström B
    J Rheumatol; 1989 Apr; 16(4):473-4. PubMed ID: 2664169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?
    Scott DL; Greenwood A; Davies J; Maddison PJ; Maddison MC; Hall ND
    Br J Rheumatol; 1990 Apr; 29(2):126-7. PubMed ID: 2182170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
    Jellum E; Aaseth J; Munthe E
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
    [No Abstract]   [Full Text] [Related]  

  • 24. Penicillamine in rheumatoid arthritis: comparison of two dose schedules [proceedings].
    Hill AG; Hill HF
    Ann Rheum Dis; 1976 Dec; 35(6):541-2. PubMed ID: 1008625
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Direct, immediate and late results of the treatment of rheumatoid arthritis with D-penicillamine].
    Matveĭkov GP; Zhivutskiĭ II; Koshelev VK; Pshonik SS
    Vopr Revm; 1978; (4):6-12. PubMed ID: 364835
    [No Abstract]   [Full Text] [Related]  

  • 27. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold.
    Paulus HE; Williams HJ; Ward JR; Reading JC; Egger MJ; Coleman ML; Samuelson CO; Willkens RF; Guttadauria M; Alarcón GS
    Arthritis Rheum; 1984 Jul; 27(7):721-7. PubMed ID: 6378208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.
    Lancet; 1973 Feb; 1(7798):275-80. PubMed ID: 4119168
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial.
    Williams HJ; Ward JR; Reading JC; Egger MJ; Grandone JT; Samuelson CO; Furst DE; Sullivan JM; Watson MA; Guttadauria M; Cathcart ES; Kaplan SB; Halla JT; Weinstein A; Plotz PH
    Arthritis Rheum; 1983 May; 26(5):581-92. PubMed ID: 6342625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
    Hurst NP; Bell AL; Nuki G
    Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that D-penicillamine alters the course of rheumatoid arthritis.
    Gibson T; Huskisson EC; Wojtulewski JA; Scott PJ; Balme HW; Burry HC; Grahame R; Hart FD
    Rheumatol Rehabil; 1976 Aug; 15(3):211-5. PubMed ID: 823633
    [No Abstract]   [Full Text] [Related]  

  • 34. A study of adjunctive copper sulphate treatment in patients with rheumatoid arthritis who have relapsed while taking D-penicillamine.
    Pullar T; Wrigley H; Newton K; Toothill C; Wright V
    Br J Clin Pharmacol; 1991 Jan; 31(1):105-7. PubMed ID: 2015161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 37. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillamine for rheumatoid arthritis.
    Med Lett Drugs Ther; 1978 Aug; 20(17):73-4. PubMed ID: 355819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.